Table 2.
Health and economic outcomes
| |
|
|
|
|
Difference between CMR and SPECT |
|
|---|---|---|---|---|---|---|
| Prevalence of CAD | Test | Total cost (€) | Effect (CAD Dx) | Utility (ΔQALY) | Cost per effect (€/CAD Dx) | Cost per utility (€/ΔQALY) |
| 0.20 |
CMR |
1,770 |
0.17 |
0.45 |
|
|
| |
SPECT |
1,657 |
0.14 |
0.33 |
−1,394 |
−1,106 |
| 0.50 |
CMR |
2,537 |
0.41 |
1.13 |
|
|
| |
SPECT |
2,425 |
0.34 |
0.83 |
−945 |
−685 |
| 0.80 |
CMR |
3,304 |
0.66 |
1.81 |
|
|
| SPECT | 3,193 | 0.55 | 1.33 | −811 | −563 | |
CAD: coronary artery disease; Dx: accurate diagnosis (of CAD); CMR: cardiac magnetic resonance; QALY: quality-adjusted life-year; SPECT: single-photon emission computed tomography.